Bill Text: TX HB3922 | 2021-2022 | 87th Legislature | Engrossed
Bill Title: Relating to information provided by health care providers and hospitals to certain patients regarding pharmaceutical manufacturer patient assistance programs for insulin.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Engrossed - Dead) 2021-05-12 - Referred to Health & Human Services [HB3922 Detail]
Download: Texas-2021-HB3922-Engrossed.html
87R21298 KKR-F | ||
By: Oliverson | H.B. No. 3922 |
|
||
|
||
relating to information provided by health care providers and | ||
hospitals to certain patients regarding pharmaceutical | ||
manufacturer patient assistance programs for insulin. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Subchapter N, Chapter 531, Government Code, is | ||
amended by adding Section 531.509 to read as follows: | ||
Sec. 531.509. INFORMATION ON PHARMACEUTICAL MANUFACTURER | ||
PATIENT ASSISTANCE PROGRAMS FOR INSULIN. (a) This section applies | ||
to health care providers and hospitals that receive uncompensated | ||
care pool payments from the commission, including: | ||
(1) federally qualified health centers as defined by | ||
42 U.S.C. Section 1396d(l)(2)(B); | ||
(2) rural health clinics as defined by 42 U.S.C. | ||
Section 1396d(l)(1); and | ||
(3) physician group practices. | ||
(b) A health care provider or hospital to which this section | ||
applies shall provide to patients who have diabetes and require | ||
insulin information regarding the availability of pharmaceutical | ||
manufacturer patient assistance programs, including copay cards, | ||
that may reduce the cost of insulin to the patients. | ||
(c) The executive commissioner shall adopt rules to | ||
implement this section. | ||
SECTION 2. If before implementing any provision of this Act | ||
a state agency determines that a waiver or authorization from a | ||
federal agency is necessary for implementation of that provision, | ||
the agency affected by the provision shall request the waiver or | ||
authorization and may delay implementing that provision until the | ||
waiver or authorization is granted. | ||
SECTION 3. This Act takes effect September 1, 2021. |